E-VIRTUE Trial to Evaluate Enfortumab Vedotin with Pembrolizumab in Rare Genitourinary Tumors
The E-VIRTUE trial is investigating the efficacy of enfortumab vedotin with or without pembrolizumab in patients with rare testicular and urinary tract cancers.